28 related articles for article (PubMed ID: 12695117)
1. The CD4 transmembrane GGXXG and juxtamembrane (C/F)CV+C motifs mediate pMHCII-specific signaling independently of CD4-LCK interactions.
Lee MS; Tuohy PJ; Kim CY; Yost PP; Lichauco K; Parrish HL; Van Doorslaer K; Kuhns MS
Elife; 2024 Apr; 12():. PubMed ID: 38639990
[TBL] [Abstract][Full Text] [Related]
2. Reciprocal TCR-CD3 and CD4 Engagement of a Nucleating pMHCII Stabilizes a Functional Receptor Macrocomplex.
Glassman CR; Parrish HL; Lee MS; Kuhns MS
Cell Rep; 2018 Jan; 22(5):1263-1275. PubMed ID: 29386113
[TBL] [Abstract][Full Text] [Related]
3. The transmembrane E3 ligase GRAIL ubiquitinates and degrades CD83 on CD4 T cells.
Su LL; Iwai H; Lin JT; Fathman CG
J Immunol; 2009 Jul; 183(1):438-44. PubMed ID: 19542455
[TBL] [Abstract][Full Text] [Related]
4. [A novel role for the TRPV1 ion channel in CD4 T cell activation].
Bertin S; Raz E
Med Sci (Paris); 2015 Feb; 31(2):135-6. PubMed ID: 25744258
[No Abstract] [Full Text] [Related]
5. Helper T cell immunity in humans with inherited CD4 deficiency.
Guérin A; Moncada-Vélez M; Jackson K; Ogishi M; Rosain J; Mancini M; Langlais D; Nunez A; Webster S; Goyette J; Khan T; Marr N; Avery DT; Rao G; Waterboer T; Michels B; Neves E; Iracema Morais C; London J; Mestrallet S; Quartier Dit Maire P; Neven B; Rapaport F; Seeleuthner Y; Lev A; Simon AJ; Montoya J; Barel O; Gómez-Rodríguez J; Orrego JC; L'Honneur AS; Soudée C; Rojas J; Velez AC; Sereti I; Terrier B; Marin N; García LF; Abel L; Boisson-Dupuis S; Reis J; Marinho A; Lisco A; Faria E; Goodnow CC; Vasconcelos J; Béziat V; Ma CS; Somech R; Casanova JL; Bustamante J; Franco JL; Tangye SG
J Exp Med; 2024 May; 221(5):. PubMed ID: 38557723
[TBL] [Abstract][Full Text] [Related]
6. Expression of Fc Fragment Receptors of Immunoglobulin G (FcγRs) in Rat Hepatic Stellate Cells.
Shen H; Zhang M; Kaita K; Minuk GY; Rempel J; Gong Y
Dig Dis Sci; 2005 Jan; 50(1):181-187. PubMed ID: 27837389
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of antitumor immunity in lung cancer by targeting myeloid-derived suppressor cell pathways.
Sawant A; Schafer CC; Jin TH; Zmijewski J; Tse HM; Roth J; Sun Z; Siegal GP; Thannickal VJ; Grant SC; Ponnazhagan S; Deshane JS
Cancer Res; 2013 Nov; 73(22):6609-20. PubMed ID: 24085788
[TBL] [Abstract][Full Text] [Related]
8. Production and detection of reactive oxygen species (ROS) in cancers.
Wu D; Yotnda P
J Vis Exp; 2011 Nov; (57):. PubMed ID: 22127014
[TBL] [Abstract][Full Text] [Related]
9. The kinase-dependent function of Lck in T-cell activation requires an intact site for tyrosine autophosphorylation.
Xu H; Littman DR
Ann N Y Acad Sci; 1995 Sep; 766():99-116. PubMed ID: 7486706
[TBL] [Abstract][Full Text] [Related]
10. The structure of CD4.
Brady RL; Barclay AN
Curr Top Microbiol Immunol; 1996; 205():1-18. PubMed ID: 8575192
[No Abstract] [Full Text] [Related]
11. Involvement of CD4 D3-D4 membrane proximal extracellular domain for the inhibitory effect of oxidative stress on activation-induced CD4 down-regulation and its possible role for T cell activation.
Nakamura K; Yube K; Miyatake A; Cambier JC; Hirashima M
Mol Immunol; 2003 May; 39(15):909-21. PubMed ID: 12695117
[TBL] [Abstract][Full Text] [Related]
12. The extracellular domain of CD4 regulates the initiation of T cell activation.
Gratton S; Haughn L; Sekaly RP; Julius M
Mol Immunol; 2000 Apr; 37(5):213-9. PubMed ID: 10930628
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of protein kinase C-mediated CD4 down-regulation by oxidative stress in T lymphocytes.
Nakamura K; Sasada T; Sono H; Yodoi J
J Immunol; 1996 Dec; 157(12):5339-49. PubMed ID: 8955181
[TBL] [Abstract][Full Text] [Related]
14. CTLA-4 suppresses proximal TCR signaling in resting human CD4(+) T cells by inhibiting ZAP-70 Tyr(319) phosphorylation: a potential role for tyrosine phosphatases.
Guntermann C; Alexander DR
J Immunol; 2002 May; 168(9):4420-9. PubMed ID: 11970985
[TBL] [Abstract][Full Text] [Related]
15. A model for antigen-specific T-cell anergy: displacement of CD4-p56(lck) signalosome from the lipid rafts by a soluble, dimeric peptide-MHC class II chimera.
Thomas S; Kumar R; Preda-Pais A; Casares S; Brumeanu TD
J Immunol; 2003 Jun; 170(12):5981-92. PubMed ID: 12794125
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
